Cargando…
Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics
We explored the effects of chitosan oligosaccharides (COS) on coronary heart disease (CHD) patients. The component of COS was measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). CHD patients were evenly assigned into the COS group (COG) and the pl...
Autores principales: | Jiang, Tiechao, Xing, Xiaohong, Zhang, Lirong, Liu, Zhen, Zhao, Jixue, Liu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431530/ https://www.ncbi.nlm.nih.gov/pubmed/30984339 http://dx.doi.org/10.1155/2019/7658052 |
Ejemplares similares
-
Chitosan oligosaccharide affects antioxidant defense capacity and placental amino acids transport of sows
por: Xie, Chunyan, et al.
Publicado: (2016) -
The Anti-inflammatory Effect of Chitosan Oligosaccharide on Heart Failure in Mice
por: Zhang, Yubiao, et al.
Publicado: (2022) -
Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota
por: Wang, Yihua, et al.
Publicado: (2021) -
The combined impact of xylo-oligosaccharides and gamma-irradiated astragalus polysaccharides on the immune response, antioxidant capacity, and intestinal microbiota composition of broilers
por: Wang, Q., et al.
Publicado: (2022) -
Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo
por: Wang, Yujie, et al.
Publicado: (2021)